Clinical trials
Active, not recruiting Small Cell Lung Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
88 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 5 |
| 2020 | 12 |
| 2021 | 15 |
| 2022 | 12 |
| 2023 | 8 |
| 2024 | 11 |
| 2025 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 88 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 11 |
| Amgen | 8 |
| AstraZeneca | 7 |
| Boehringer Ingelheim | 4 |
| Merck Sharp & Dohme LLC | 4 |
| Jonsson Comprehensive Cancer Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| Norwegian University of Science and Technology | 2 |
| 23andMe, Inc. | 1 |
| AbbVie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 88 |
| Lung Neoplasms | 18 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Melanoma | 9 |
| Breast Neoplasms | 8 |
| Carcinoma, Renal Cell | 8 |
| Triple Negative Breast Neoplasms | 8 |
| Colorectal Neoplasms | 7 |
| Prostatic Neoplasms | 7 |
| Carcinoma, Transitional Cell | 6 |
Trials
Showing 76 to 88 of 88. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.